研究者詳細 - 佐治　重衡

論文 - 佐治　重衡

分割表示226 件中 121 - 140 件目／全件表示 >>

Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan.

Sawaki M, Yamada A, Kumamaru H, Miyata H, Nakayama K, Shimizu C, Miyashita M, Honma N, Taira N, Saji S

Breast cancer 28 ( 1 ) 1 - 8 2021年1月（ ISSN:1340-6868 ）

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.

Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Shimizu A, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Kinoshita T, Kai Y, Kitada M, Sato Y, Jimbo K, Sato N, Ishiguro H, Takada M, Ohashi Y, Ohno S

The Lancet. Oncology 22 ( 1 ) 74 - 84 2021年1月（ ISSN:1470-2045 ）

日本の高齢乳癌患者の臨床病理学的特徴、practical treatment、予後、臨床上の問題点(Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan)

Sawaki Masataka, Yamada Akimitsu, Kumamaru Hiraku, Miyata Hiroaki, Nakayama Kanako, Shimizu Chikako, Miyashita Mika, Honma Naoko, Taira Naruto, Saji Shigehira

Breast Cancer 28 ( 1 ) 1 - 8 2021年1月（ ISSN:1340-6868 ）

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.

Mittendorf EA, Zhang H, Barrios CH, Saji S, Jung KH, Hegg R, Koehler A, Sohn J, Iwata H, Telli ML, Ferrario C, Punie K, Penault-Llorca F, Patel S, Duc AN, Liste-Hermoso M, Maiya V, Molinero L, Chui SY, Harbeck N.

Lancet. 396 ( 10257 ) 1090 - 1100 2020年10月

Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.

Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S.

Journal for immunotherapy of cancer 8 ( 2 ) e001164 - e001164 2020年10月

談論　がんゲノム医療の現状について

佐治重衡

福島県病院協会会報 111 3 - 5 2020年6月

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).

Yamashita T, Masuda N, Saji S, Araki K, Ito Y, Takano T, Takahashi M, Tsurutani J, Koizumi K, Kitada M, Kojima Y, Sagara Y, Tada H, Iwasa T, Kadoya T, Iwatani T, Hasegawa H, Morita S, Ohno S

Trials 21 ( 1 ) 391 2020年5月

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

Shimoi T, Nagai SE, Yoshinami T, Takahashi M, Arioka H, Ishihara M, Kikawa Y, Koizumi K, Kondo N, Sagara Y, Takada M, Takano T, Tsurutani J, Naito Y, Nakamura R, Hattori M, Hara F, Hayashi N, Mizuno T, Miyashita M, Yamashita N, Yamanaka T, Saji S, Iwata H, Toyama T

Breast Cancer. 27 ( 3 ) 322 - 331 2020年5月（ ISSN:1340-6868 ）

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.

Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S

Breast cancer (Tokyo, Japan) 27 ( 3 ) 389 - 398 2020年5月（ ISSN:1340-6868 ）

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.

Park YH, Senkus-Konefka E, Im SA, Pentheroudakis G, Saji S, Gupta S, Iwata H, Mastura MY, Dent R, Lu YS, Yin Y, Smruti BK, Toyama T, Malwinder S, Lee SC, Tseng LM, Kim JH, Kim TY, Suh KJ, Cardoso F, Yoshino T, Douillard JY

Annals of oncology : official journal of the European Society for Medical Oncology 31 ( 4 ) 451 - 469 2020年4月（ ISSN:09237534 ）

Pertuzumab, Trastuzumab, and Docetaxel for HER2-positive Metastatic Breast Cancer (CLEOPATRA): End-Of-Study Results From a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Study

Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, Ciruelos E, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J; CLEOPATRA study group

Lancet Oncol. 21 ( 4 ) 519 - 530 2020年4月

Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study.

Ozaki A, Nomura S, Leppold C, Tsubokura M, Sawano T, Tsukada M, Morita T, Tanimoto T, Saji S, Kato S, Yamaoka K, Nakata Y, Ohira H

Clinical breast cancer 20 ( 2 ) e127 - e150 2020年4月（ ISSN:1526-8209 ）

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study.

Tamura K, Imamura CK, Takano T, Saji S, Yamanaka T, Yonemori K, Takahashi M, Tsurutani J, Nishimura R, Sato K, Kitani A, Ueno NT, Mushiroda T, Kubo M, Fujiwara Y, Tanigawara Y.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 36 ( 6 ) 558 - 566 2020年2月（ ISSN:0732-183X ）

Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition.

Yamauchi C, Yoshimura M, Sekiguchi K, Hamamoto Y, Nakajima N, Sanuki N, Ogo E, Oguchi M, Saji S, Iwata H

Breast cancer (Tokyo, Japan) 27 ( 1 ) 9 - 16 2020年1月（ ISSN:1340-6868 ）

記述言語：英語掲載種別：研究論文（学術雑誌）

DOI ： 10.1007/s12282-019-01019-5

DOI ： 10.1007/s12282-021-01255-8

PubMed

その他リンク： https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106334028&origin=inward

The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition.

Inokuchi M, Kutomi G, Kijima Y, Sakai T, Sawaki M, Shien T, Hanamura N, Yano K, Wada N, Saji S, Iwata H

Breast cancer (Tokyo, Japan) 27 ( 1 ) 4 - 8 2020年1月（ ISSN:1340-6868 ）

記述言語：英語掲載種別：研究論文（学術雑誌）

DOI ： 10.1007/s12282-019-01030-w

DOI ： 10.1007/s12282-021-01256-7.

PubMed

その他リンク： https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106244306&origin=inward

日本乳癌学会「乳癌診療ガイドライン2018年版」健診・画像診断(The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition)

Uematsu Takayoshi, Nakashima Kazutaka, Kikuchi Mari, Kubota Kazunori, Suzuki Akihiko, Nakano Shogo, Hirokaga Kouichi, Yamaguchi Ken, Saji Shigehira, Iwata Hiroji

Breast Cancer 27 ( 1 ) 17 - 24 2020年1月（ ISSN:1340-6868 ）

記述言語：英語掲載種別：研究論文（学術雑誌）

DOI ： 10.1007/s12282-019-01025-7.

DOI ： 10.1007/s12282-021-01251-y.

その他リンク： https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105994728&origin=inward

Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient.

Iwata H, Saji S, Ikeda M, Inokuchi M, Uematsu T, Toyama T, Horii R, Yamauchi C

Breast cancer (Tokyo, Japan) 27 ( 1 ) 1 - 3 2020年1月（ ISSN:1340-6868 ）

記述言語：英語掲載種別：研究論文（学術雑誌）

DOI ： 10.1007/s12282-019-01021-x

DOI ： 10.1007/s12282-021-01253-w

PubMed

その他リンク： https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106326178&origin=inward

Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report.

Gonda K, Akama T, Nakamura T, Hashimoto E, Kyoya N, Rokkaku Y, Maejima Y, Horita S, Tachibana K, Abe N, Ohtake T, Shimomura K, Kono K, Saji S, Takenoshita S, Higashihara E

Journal of medical case reports 13 ( 1 ) 381 2019年12月

【新しい抗体薬;ADC】乳がんに対するADC

名取穣, 佐治重衡

がん分子標的治療 17 ( 2 ) 128 - 132 2019年12月（ ISSN:1347-6955 ）

Characteristics of adverse events of endocrine therapies among older patients with breast cancer.

Honma N, Makita M, Saji S, Mikami T, Ogata H, Horii R, Akiyama F, Iwase T, Ohno S

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 27 ( 10 ) 3813 - 3822 2019年10月（ ISSN:0941-4355 ）

　前のページ - 次のページ　

<佐治 重衡>

論文 - 佐治 重衡

<佐治　重衡>

論文 - 佐治　重衡